genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
He Jiankui Research Prompts U.S. Academies, U.K. Society to Create Germline…
News
Amgen Offers $167M for Cancer Collaboration Partner Nuevolution
News
Anti-Aging Drug Candidates ID’d Using Transcriptomes of Long-Lived Worms
Natural Products
Civil War Battlefield Natural Therapies Found to be Effective against Modern-Day…
News
Tissue Engineering Improved by Use of Molecular Tethers
Insights
Vaccine Development
NIH Solicits Research into Vaccines to Protect against Opioid Use
Neuroscience
Human-Derived Brain Models
Artificial Intelligence
Hey Google. Is This Lung Cancer?
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
Tech Exclusives
Rising to the Challenge of Intensifying Bioprocesses
A-Lists
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
A-Lists
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Insights
Top 10 Sequencing Companies
May 2019 Vol. 39 No. 5
Top 10 Immuno-Oncology Collaborations
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Vaccine Development
NIH Solicits Research into Vaccines to Protect against Opioid Use
News
He Jiankui Research Prompts U.S. Academies, U.K. Society to Create Germline…
News
Amgen Offers $167M for Cancer Collaboration Partner Nuevolution
News
Anti-Aging Drug Candidates ID’d Using Transcriptomes of Long-Lived Worms
Magazine
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
May 2019 Vol. 39 No. 5
Genomics’ “Green” Future
May 2019 Vol. 39 No. 5
Crafting a More Efficient CAR T-Cell Industry
May 2019 Vol. 39 No. 5
All About That Base Editing
May 2019 Vol. 39 No. 5
Signs, Portents, and Immuno-Oncology Biomarkers
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Podcasts
GENcast: Explore, Learn, and Collaborate on Viral Safety in Biomanufacturing
May 2019 Vol. 39 No. 5
A Scalable Adenovirus Production Process from Cell Culture to Purified Bulk…
Upcoming Webinars
Recent Advances and the Future of Antibody Engineering
Videos
3D Bioprinted Organ Just Took Its First “Breath”
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Drug Discovery
Vaccine Development
Vaccine Development
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Vaccine Development
NIH Solicits Research into Vaccines to Protect against Opioid Use
Vaccine Development
FDA Approves Sanofi’s Dengue Prevention Vaccine Dengvaxia in Narrower Patient Population
Vaccine Development
A Scalable Adenovirus Production Process, from Cell Culture to Purified Bulk
Vaccine Development
A Shot in the Arm for Vaccine Manufacturing
Vaccine Development
Potential Leukemia Drug Target Found in Epigenetic Protein
Vaccine Development
Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline
Vaccine Development
Flesh-Eating Bacteria’s Genomic/Transcriptomic Trigger Found
Vaccine Development
Utilizing External Collaboration to Accelerate Vaccine Development
Vaccine Development
Improved Humanized Mice Enhance Vaccine Development
Vaccine Development
Cancer Vaccine Kills Cancer Cells and the Cells They Dupe
Vaccine Development
Moderna Files for Largest-Ever Biotech IPO, Seeking to Raise $500M
Vaccine Development
Probiotic, Live Vaccine Both Curb Cholera
Vaccine Development
Vical Halts Development of HSV-2 Vaccine after Phase II Failure
Vaccine Development
Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership
Vaccine Development
Bavarian Nordic Wins Up-to-$36M DoD Contract toward Equine Encephalitis Vaccine
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![C. elegans. [Source: Arturo Agostino]](https://www.genengnews.com/wp-content/uploads/2018/08/169244_web1201231412-218x150.jpg "Anti-Aging Drug Candidates ID’d Using Transcriptomes of Long-Lived Worms")
![Some species of Vibrio bacteria (blue) can cause cholera in humans. A version of Vibrio cholerae designed to be harmless may one day protect people against the dangerous form of the bacteria. [Tina Carvalho/University of Hawaii at Manoa/CC BY 2.0]](https://www.genengnews.com/wp-content/uploads/2018/08/Jun14_2018_UnivHawaii_Vibrio1962072475-324x160.jpg "Probiotic, Live Vaccine Both Curb Cholera")
![Sanofi’s global vaccines unit Sanofi Pasteur has launched an up-to-$805 million partnership with Translate Bio to develop messenger RNA vaccines for up to five undisclosed infectious disease pathogens. [Ryan Jeffs/Wikicommons]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar14_2017_WikiCommons_MicroRNAAndmRNAVisualization2173942127-324x160.jpg "Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership")
